Cagrilintide × NextGen Peptides - Lab Test, January 2026
Test results
About this test
Cagrilintide 5mg from NextGen Peptides achieves 99.646% purity according to this independent HPLC analysis conducted by Janoshik Labs on January 16, 2026. The tested quantity was 5.62mg, exceeding the stated label amount of 5mg.
Cagrilintide is a GLP-1 receptor agonist researched for weight management and metabolic regulation. A purity level of 99.646% demonstrates pharmaceutical-grade synthesis with minimal contamination and high product consistency.
The certificate of analysis (Task #99965) is available for verification at www.janoshik.com/verify/ with the unique key 3W58N-RED1KG. The test includes assessment of the peptide vial or vials.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.